I think the only positive for this statement is that MSB are sticking to their guns in terms of recruitment subjects to ensure the best chance of success in terms of data
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-382
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.42 |
Change
-0.025(1.74%) |
Mkt cap ! $1.627B | |||
| Open | High | Low | Value | Volume |
| $1.44 | $1.46 | $1.40 | $1.104M | 773.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 10735 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 22000 | 8 |
View Market Depth
| Last trade - 11.17am 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |